glp-1 bowel obstruction law firm in louisiana Ozempic Lawsuit for Blindness, Stomach Paralysis and Injury Claims Ozempic Lawsuit [2026 Update]

The pill era has ushered in a Wild-West-style land-grab for GLP-1 market share but the horizon seems to keep expanding.

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

The competitive profile of 16 week data for Amylin agonists vs

Results Each propensity-score matched group constituted 3424 patients, 45% women, 21% had a history of cardiovascular disease, and 13.9% were treated with sodium-glucose cotransporter-2 inhibitors at baseline

These early exits from therapy not only undermine clinical outcomes but also distort commercial forecasts and ROI projections